BR112020027097A2 - Composições de combinação de canabidiol - Google Patents

Composições de combinação de canabidiol Download PDF

Info

Publication number
BR112020027097A2
BR112020027097A2 BR112020027097-0A BR112020027097A BR112020027097A2 BR 112020027097 A2 BR112020027097 A2 BR 112020027097A2 BR 112020027097 A BR112020027097 A BR 112020027097A BR 112020027097 A2 BR112020027097 A2 BR 112020027097A2
Authority
BR
Brazil
Prior art keywords
glucosamine
cbd
fact
modalities
composition according
Prior art date
Application number
BR112020027097-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Golan Vaknin
Tami Bar
Original Assignee
Companion Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Companion Sciences Llc filed Critical Companion Sciences Llc
Publication of BR112020027097A2 publication Critical patent/BR112020027097A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112020027097-0A 2018-07-02 2019-07-01 Composições de combinação de canabidiol BR112020027097A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862692865P 2018-07-02 2018-07-02
US62/692,865 2018-07-02
PCT/US2019/040043 WO2020009950A1 (en) 2018-07-02 2019-07-01 Cannabidiol combination compositions

Publications (1)

Publication Number Publication Date
BR112020027097A2 true BR112020027097A2 (pt) 2021-03-30

Family

ID=69060564

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020027097-0A BR112020027097A2 (pt) 2018-07-02 2019-07-01 Composições de combinação de canabidiol

Country Status (8)

Country Link
US (1) US20210275556A1 (https=)
EP (1) EP3817750A4 (https=)
JP (1) JP2021532171A (https=)
CN (1) CN112930183A (https=)
AU (1) AU2019299213A1 (https=)
BR (1) BR112020027097A2 (https=)
CA (1) CA3105082A1 (https=)
WO (1) WO2020009950A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3755372A1 (en) 2018-02-23 2020-12-30 Nicola Michael Spirtos Cannabis based therapeutic and method of use
IT201900016709A1 (it) * 2019-09-19 2021-03-19 Aqma Italia S P A Composizione antidolorifica e antinfiammatoria ad uso locale
US20210212950A1 (en) * 2020-01-15 2021-07-15 Resurgent Pharmaceuticals, Inc. Orally deliverable formulation to prevent all cause mortality and cardiovascular events
US11364255B2 (en) * 2020-07-01 2022-06-21 Karallief, Inc. Therapeutic herbal compositions for improving joint health
BR102020023664A2 (pt) * 2020-07-02 2022-01-11 Yuzu Llc Composições compreendendo canabidiol e flavononas
EP4182026A4 (en) * 2020-07-17 2024-10-02 India Globalization Capital, Inc. COMPOSITION BASED ON CANNABIDIOL (CBD) AND METHOD FOR TREATING PAIN

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
CN101227916A (zh) * 2005-05-24 2008-07-23 维尔金有限公司 预防和治疗发炎相关状况的组合物和方法
JP5204578B2 (ja) * 2007-07-31 2013-06-05 全薬工業株式会社 関節痛改善用組成物、関節痛改善剤、あるいは食品
ES2541485T3 (es) * 2010-10-19 2015-07-21 Parenteral, A.S. Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol
SG10201402819WA (en) * 2014-06-02 2016-01-28 Beauty Nation Pte Ltd Composition for prevention and treatment of joint pain and the method of preparation thereof
US9486476B2 (en) * 2014-08-05 2016-11-08 Natures Products, Inc Fast acting joint relief formulations
US10398776B1 (en) * 2014-11-03 2019-09-03 Essential Green Goodness LLC Phonophoretic cannabidiol composition and transdermal delivery system
CA2976004C (en) * 2015-02-05 2020-06-02 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
US10542770B2 (en) * 2016-03-18 2020-01-28 Aceso Wellness LLC Cannabinoid emulsion product and process for making the same
CA3025208A1 (en) * 2016-05-24 2017-11-30 Bol Pharma Ltd. Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
US10945967B2 (en) * 2017-05-30 2021-03-16 Jae Wang. Song Formulations of a transdermal patch for pain management
US20190000794A1 (en) * 2017-12-27 2019-01-03 Daniel S. Tanaka Transmucosal cannabinoid formulation including a chitosan excipeint
AU2019251357B2 (en) * 2018-04-09 2023-10-05 Portland Technology Holdings Llc Hemp extract for treatment of pain in animals
CN110575432B (zh) * 2018-06-08 2021-10-12 汉义生物科技（北京）有限公司 一种含有大麻二酚的组合物及其在动物用品中的应用
WO2020021545A1 (en) * 2018-07-25 2020-01-30 Bol Pharma Ltd. Cannabidiol and glucosamine for treating inflammatory joint diseases

Also Published As

Publication number Publication date
EP3817750A4 (en) 2022-05-04
CA3105082A1 (en) 2020-01-09
WO2020009950A1 (en) 2020-01-09
JP2021532171A (ja) 2021-11-25
US20210275556A1 (en) 2021-09-09
CN112930183A (zh) 2021-06-08
EP3817750A1 (en) 2021-05-12
AU2019299213A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
BR112020027097A2 (pt) Composições de combinação de canabidiol
TW202132247A (zh) 大麻二酚型大麻素化合物
JP2022546928A (ja) カンナビジオールを含む局所製剤、組成物の調製方法およびその使用
TW202132248A (zh) 大麻二酚型大麻素化合物
CN112912072A (zh) 组合疗法治疗肌萎缩侧索硬化症及相关疾病
BR112016010422B1 (pt) Suplemento dietético e método de tratamento para melhorar o desempenho ou energia física em um indivíduo
BR112020004947A2 (pt) canabidiol transdérmico sintético para o tratamento de epilepsia focal em adultos
KR102350519B1 (ko) 말초성 염증 및 통증을 감소시키는데 유용한 울금 및 에키네시아 안구스티폴리아의 추출물을 함유하는 조성물
JP7103752B2 (ja) 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤
JP2002518438A (ja) 不安状態または鬱病による神経および行動変化の予防および／または治療のための神経保護組成物
ITTO20090777A1 (it) Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'
CN106456637B (zh) (s)-吡吲哚及其药学上可接受的盐的药学用途
KR20220136418A (ko) 관절 건강을 개선하고 관절염을 치료하기 위한 알피니아 및 기타 식물의 추출물을 포함하는 조성물
US20140243354A1 (en) Combinations of indigo naturalis and berberine and uses thereof
CN100522983C (zh) 梓醇及其同系物的医药用途
ES2715373T3 (es) Composiciones terapéuticas y nutricionales para el tratamiento del síndrome del intestino irritable
KR102232198B1 (ko) 의약으로서 사용되기 위한 (r)-펄린돌 및 약학적으로 허용 가능한 그의 염
CN108686023A (zh) 一种治疗老年性皮肤瘙痒的止痒润肤精油
BR112014008430B1 (pt) Preparação de ovos com propriedades de regeneração, analgésica e/ou anti- inflamatória, seu processo de preparação e seus usos
CN104523925B (zh) 一种中药组合物及其在解热并促排便方面的应用
JP2023523275A (ja) 疼痛管理のためのカンナビクロメン製剤
BRPI0618209A2 (pt) composições farmacêuticas que compreendem combinações de analgésicos e anti-convulsivos para o tratamento de dor aguda e crÈnica
CN115461051B (zh) 药学组合物及其于治疗帕金森氏症的用途
WO2006117184A2 (en) Veterinary composition
HAMMAD et al. Effects of Famotidine and Naproxen on Serum Protein and Lipid Metabolism in Quails: An Ex situ Pharmacokinetic Study.

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2781 DE 24/04/2024.